Sqi Diagnostics Stock Current Valuation
| SQIDFDelisted Stock | USD 0.01 0.00 0.00% |
Valuation analysis of SQI Diagnostics helps investors to measure SQI Diagnostics' intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that SQI Diagnostics' price fluctuation is somewhat reliable at this time. Calculation of the real value of SQI Diagnostics is based on 3 months time horizon. Increasing SQI Diagnostics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the SQI pink sheet is determined by what a typical buyer is willing to pay for full or partial control of SQI Diagnostics. Since SQI Diagnostics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of SQI Pink Sheet. However, SQI Diagnostics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0149 | Real 0.0127 | Hype 0.0149 | Naive 0.0149 |
The real value of SQI Pink Sheet, also known as its intrinsic value, is the underlying worth of SQI Diagnostics Company, which is reflected in its stock price. It is based on SQI Diagnostics' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of SQI Diagnostics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of SQI Diagnostics helps investors to forecast how SQI pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of SQI Diagnostics more accurately as focusing exclusively on SQI Diagnostics' fundamentals will not take into account other important factors: SQI Diagnostics Company Current Valuation Analysis
SQI Diagnostics' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current SQI Diagnostics Current Valuation | 34.24 M |
Most of SQI Diagnostics' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, SQI Diagnostics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, SQI Diagnostics has a Current Valuation of 34.24 M. This is 99.76% lower than that of the Health Care Equipment & Supplies sector and 99.56% lower than that of the Health Care industry. The current valuation for all United States stocks is 99.79% higher than that of the company.
SQI Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses SQI Diagnostics' direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of SQI Diagnostics could also be used in its relative valuation, which is a method of valuing SQI Diagnostics by comparing valuation metrics of similar companies.SQI Diagnostics is currently under evaluation in current valuation category among its peers.
SQI Fundamentals
| Return On Equity | -12.54 | |||
| Return On Asset | -0.94 | |||
| Profit Margin | (2.29) % | |||
| Operating Margin | (1.71) % | |||
| Current Valuation | 34.24 M | |||
| Shares Outstanding | 406.25 M | |||
| Shares Owned By Insiders | 51.02 % | |||
| Shares Owned By Institutions | 24.31 % | |||
| Price To Earning | (2.35) X | |||
| Price To Book | 16.12 X | |||
| Price To Sales | 3.91 X | |||
| Revenue | 8.1 M | |||
| Gross Profit | 3.1 M | |||
| EBITDA | (12.12 M) | |||
| Net Income | (18.52 M) | |||
| Cash And Equivalents | 3.96 M | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 6.3 M | |||
| Debt To Equity | 4.64 % | |||
| Current Ratio | 0.59 X | |||
| Book Value Per Share | (0.03) X | |||
| Cash Flow From Operations | (9.82 M) | |||
| Earnings Per Share | (0.02) X | |||
| Number Of Employees | 21 | |||
| Beta | -0.0648 | |||
| Market Capitalization | 34.43 M | |||
| Total Asset | 9.31 M | |||
| Retained Earnings | (55.6 M) | |||
| Working Capital | 1.09 M | |||
| Current Asset | 1.67 M | |||
| Current Liabilities | 584 K | |||
| Z Score | -7.3 | |||
| Net Asset | 9.31 M |
About SQI Diagnostics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze SQI Diagnostics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of SQI Diagnostics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of SQI Diagnostics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Consideration for investing in SQI Pink Sheet
If you are still planning to invest in SQI Diagnostics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the SQI Diagnostics' history and understand the potential risks before investing.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |